Molecule of the month: lisdexamfetamine mesilate.
D000818:Animals; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000523:psychology; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002652:Child Behavior / Q000187:drug effects; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use*; D004348:Drug Labeling; D006801:Humans; D000069478:Lisdexamfetamine Dimesylate; D016896:Treatment Outcome
D000697:Central Nervous System Stimulants; D000069478:Lisdexamfetamine Dimesylate; D003913:Dextroamphetamine